Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20120430009593N14Phase 2Completed
Phase 2, randomised, single-blind trial in breast cancer comparing Lidocaine group with Fentanyl group (2 arms). Primary endpoint: Apoptosis index. Started Jan 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20120430009593N14.